CBD AND INFLAMMATORY BOWEL DISEASE
A Randomized, Double-blind, Placebo-controlled,
Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract
in the Symptomatic Treatment of Ulcerative Colitis.
Irving PM, Iqbal T, Nwokolo C, Subramanian S, Bloom S, Prasad N,
Hart A, Murray C, Lindsay JO, Taylor A, Barron R, Wright S.
Inflamm Bowel Dis. 2018 Mar 19;24(4):714-724. doi:
10.1093/ibd/izy002.
PMID:29538683
Association between Inflammatory Bowel Disease and
Cholelithiasis: A Nationwide Population-Based Cohort Study.
Chen CH, Lin CL, Kao CH.
Int J Environ Res Public Health. 2018 Mar 14;15(3). pii: E513. doi:
10.3390/ijerph15030513.
PMID:29538289
Free PMC Article
Cannabidiol and palmitoylethanolamide are
anti-inflammatory in the acutely inflamed human colon.
Couch DG, Tasker C, Theophilidou E, Lund JN, O'Sullivan SE.
Clin Sci (Lond). 2017 Oct 25;131(21):2611-2626. doi:
10.1042/CS20171288. Print 2017 Nov 1.
PMID:28954820
+
Abnormal cannabidiol attenuates experimental
colitis in mice, promotes wound healing and inhibits neutrophil
recruitment.
Krohn RM, Parsons SA, Fichna J, Patel KD, Yates RM, Sharkey KA,
Storr MA.
J Inflamm (Lond). 2016 Jul 14;13:21. doi: 10.1186/s12950-016-0129-0.
eCollection 2016.
PMID:27418880
Free PMC Article
Cannabis induces a clinical response in patients
with Crohn's disease: a prospective placebo-controlled study.
Naftali T, Bar-Lev Schleider L, Dotan I, Lansky EP, Sklerovsky
Benjaminov F, Konikoff FM.
Clin Gastroenterol Hepatol. 2013 Oct;11(10):1276-1280.e1. doi:
10.1016/j.cgh.2013.04.034. Epub 2013 May 4.
PMID:23648372
Cannabidiol in inflammatory bowel diseases: a
brief overview.
Esposito G, Filippis DD, Cirillo C, Iuvone T, Capoccia E, Scuderi C,
Steardo A, Cuomo R, Steardo L.
Phytother Res. 2013 May;27(5):633-6. doi: 10.1002/ptr.4781. Epub
2012 Jul 20. Review.
PMID:22815234
Topical and systemic cannabidiol improves
trinitrobenzene sulfonic acid colitis in mice.
Schicho R, Storr M.
Pharmacology. 2012;89(3-4):149-55. doi: 10.1159/000336871. Epub 2012
Mar 12.
PMID:22414698
Free PMC Article
Cannabidiol reduces intestinal inflammation
through the control of neuroimmune axis.
De Filippis D, Esposito G, Cirillo C, Cipriano M, De Winter BY,
Scuderi C, Sarnelli G, Cuomo R, Steardo L, De Man JG, Iuvone T.
PLoS One. 2011;6(12):e28159. doi: 10.1371/journal.pone.0028159. Epub
2011 Dec 6.
PMID:22163000
Free PMC Article
The effects of Delta-tetrahydrocannabinol and
cannabidiol alone and in combination on damage, inflammation and
in vitro motility disturbances in rat colitis.
Jamontt JM, Molleman A, Pertwee RG, Parsons ME.
Br J Pharmacol. 2010 Jun;160(3):712-23. doi:
10.1111/j.1476-5381.2010.00791.x.
PMID:20590574
Free PMC Article Chronic inflammatory bowel disease in a patient
with common variable immunodeficiency.
Kütükçüler N, Yağci RV, Aydoğdu S, Aksu G, Genç B.
Turk J Pediatr. 2001 Jan-Mar;43(1):88-90.
PMID:11297168